Your browser doesn't support javascript.
loading
Actinium-225 Targeted Agents: Where Are We Now?
Mourtada, Firas; Tomiyoshi, Katsumi; Sims-Mourtada, Jennifer; Mukai-Sasaki, Yuki; Yagihashi, Takayuki; Namiki, Yuta; Murai, Taro; Yang, David J; Inoue, Tomio.
Affiliation
  • Mourtada F; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA. Electronic address: firas.mourtada@jefferson.edu.
  • Tomiyoshi K; Advanced Medical Center, Shonan Kamakura General Hospital, Kamakura, Japan.
  • Sims-Mourtada J; Helen F. Graham Cancer Center & Research Institute, Newark, DE.
  • Mukai-Sasaki Y; Advanced Medical Center, Shonan Kamakura General Hospital, Kamakura, Japan; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Yagihashi T; Advanced Medical Center, Shonan Kamakura General Hospital, Kamakura, Japan.
  • Namiki Y; Advanced Medical Center, Shonan Kamakura General Hospital, Kamakura, Japan.
  • Murai T; Advanced Medical Center, Shonan Kamakura General Hospital, Kamakura, Japan.
  • Yang DJ; Advanced Medical Center, Shonan Kamakura General Hospital, Kamakura, Japan.
  • Inoue T; Advanced Medical Center, Shonan Kamakura General Hospital, Kamakura, Japan.
Brachytherapy ; 22(6): 697-708, 2023.
Article in En | MEDLINE | ID: mdl-37690972

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brachytherapy / Neoplasms Limits: Humans Language: En Journal: Brachytherapy Journal subject: RADIOTERAPIA Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brachytherapy / Neoplasms Limits: Humans Language: En Journal: Brachytherapy Journal subject: RADIOTERAPIA Year: 2023 Document type: Article